Blog

Essential Medical Inc. Announces Successful Live Case at TCT

November 8, 2016

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today the first live MANTA case at the Transcatheter Therapeutics conference (TCT) in Washington DC.  TCT is the largest annual interventional cardiology conference in North America. The case was performed live on Monday October 31st by […]

Read More

Pennovation Center Poised to Rewire Science, Spirit of Entrepreneurship

October 31, 2016

Every shimmering detail of the University of Pennsylvania’s new business incubator and lab is cutting edge, right down the 3D printed scissors ushered on stage by a robot to cut the ceremonial ribbon. Over the past few months, the futuristic Pennovation Center has quietly gotten to work on a mission that seeks nothing less than […]

Read More

Cloudnexa Places Second as the Region’s Fastest-Growing Business

October 31, 2016

Cloudnexa, internationally recognized as a premier cloud service provider, has ranked in second place of the prestigious Philadelphia 100® list for 2016. The Philadelphia 100® has been the hallmark of entrepreneurial achievement in the region since 1988. Each year, the project identifies and honors the 100 fastest-growing, privately held entrepreneurial companies in the Greater Philadelphia […]

Read More

ZSX Medical wins $100K at angel group Keiretsu Forum’s annual expo

October 28, 2016

ZSX Medical, a medical device company based out of a life sciences coworking space on Drexel’s campus, won the top prize — a $100,000 investment — at the Keiretsu Forum Mid-Atlantic’s fourth annual Angel Capital Expo on Wednesday. At the angel group’s expo, held at Drexel University’s Bossone Research Center, 15 companies pitched. Following the […]

Read More

QR Pharma Raises $800,000 of Series A Preferred Stock

October 28, 2016

QR Pharma, Inc., a privately held biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases, has closed on $800,000 of Series A Preferred Stock financing. Existing investors Robin Hood Ventures and individual angels filled this round. QR Pharma will use the funding to continue to develop its lead compound, […]

Read More

Previous Next